Regulatory Action Initiated Against Top Executives of Tigermed

Stock News

05/12

Hangzhou Tigermed Consulting Co.,Ltd. (300347.SZ) has announced that its actual controllers, Ye Xiaoping and Cao Xiaochun, each received a "Case Filing Notice" from the China Securities Regulatory Commission (CSRC) on May 12, 2026. The notices, numbered 01120260019 and 01120260018 respectively, indicate that the CSRC has decided to initiate investigations against Ye Xiaoping and Cao Xiaochun. This action is based on suspected violations of information disclosure regulations related to changes in shareholdings of Tigermed, in accordance with laws and regulations including the Securities Law of the People's Republic of China and the Administrative Penalty Law of the People's Republic of China.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/1189856154"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1189856154\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1189856154?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-12 22:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1189856154","market":"nz","top_or_hot":-1,"title":"Regulatory Action Initiated Against Top Executives of Tigermed","media":"Stock News","content":"<p>Hangzhou Tigermed Consulting Co.,Ltd. (300347.SZ) has announced that its actual controllers, Ye Xiaoping and Cao Xiaochun, each received a \"Case Filing Notice\" from the China Securities Regulatory Commission (CSRC) on May 12, 2026. The notices, numbered 01120260019 and 01120260018 respectively, indicate that the CSRC has decided to initiate investigations against Ye Xiaoping and Cao Xiaochun. This action is based on suspected violations of information disclosure regulations related to changes in shareholdings of Tigermed, in accordance with laws and regulations including the Securities Law of the People's Republic of China and the Administrative Penalty Law of the People's Republic of China.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Regulatory Action Initiated Against Top Executives of Tigermed</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRegulatory Action Initiated Against Top Executives of Tigermed\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time smaller\">2026-05-12 22:03</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Hangzhou Tigermed Consulting Co.,Ltd. (300347.SZ) has announced that its actual controllers, Ye Xiaoping and Cao Xiaochun, each received a \"Case Filing Notice\" from the China Securities Regulatory Commission (CSRC) on May 12, 2026. The notices, numbered 01120260019 and 01120260018 respectively, indicate that the CSRC has decided to initiate investigations against Ye Xiaoping and Cao Xiaochun. This action is based on suspected violations of information disclosure regulations related to changes in shareholdings of Tigermed, in accordance with laws and regulations including the Securities Law of the People's Republic of China and the Administrative Penalty Law of the People's Republic of China.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"300347","symbol_name":"泰格醫藥","start_time":0,"source_url":"","article_id":"1189856154","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1189856154","pubTimestamp":1778594619,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Hangzhou Tigermed Consulting Co.,Ltd. (300347.SZ) has announced that its actual controllers, Ye Xiaoping and Cao Xiaochun, each received a \"Case Filing Notice\" from the China Securities Regulatory...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"300347":"泰格医药","BK1141":"生命科学工具和服务","BK0028":"国家队","BK1583":"高瓴概念","BK1576":"医药外包概念","03347":"泰格医药","BK0216":"研究试验","LU1146622755.USD":"安本中国A股股票基金A Acc","BK0174":"增持","LU1820825898.SGD":"Aberdeen Standard SICAV I - China A Share Equity A Acc SGD-H","BK0077":"质押式回购"},"translate_title":"对泰格医药高管发起监管行动","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"300347":1,"03347":1},"content_text":"Hangzhou Tigermed Consulting Co.,Ltd. (300347.SZ) has announced that its actual controllers, Ye Xiaoping and Cao Xiaochun, each received a \"Case Filing Notice\" from the China Securities Regulatory Commission (CSRC) on May 12, 2026. The notices, numbered 01120260019 and 01120260018 respectively, indicate that the CSRC has decided to initiate investigations against Ye Xiaoping and Cao Xiaochun. This action is based on suspected violations of information disclosure regulations related to changes in shareholdings of Tigermed, in accordance with laws and regulations including the Securities Law of the People's Republic of China and the Administrative Penalty Law of the People's Republic of China.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"executive","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}